Video

View G. Steven Burrill's Presentation from BioConference Live
November 17, 2009.

View video 

Podcast

Jerry Flanagan, healthcare policy director for ConsumerWatchdog, discusses his group’s lawsuit against Anthem Blue Cross of California over its rate hikes, what they mean for healthcare reform, and why the proposed healthcare legislation wouldn’t have prevented Anthem from instituting the rate increases in the first place.
Hear the podcast 

G. Steven Burrill

Welcome from the CEO

Flash required to view this video. Download the latest version here

 G. Steven Burrill 

Burrill Conferences

Sponsors

GoldSilverBronzeEvent Partners

Life Sciences Conferences

The Burrill Personalized Medicine Meeting

Agenda
AGENDA


Monday, November 10, 2008

7:30 – 8:30 a.m.
Breakfast & Registration

8:30 – 8:45 a.m.
Welcome & Introduction
- Caroline A. Kovac, PhD, Managing Director, Burrill & Company

8:45 – 10:00 a.m.
Industry Update:
State of the Personalized, Predictive and Preventative Medicine World
- G. Steven Burrill, CEO, Burrill & Company

10:00 – 10:30 a.m.
Break

10:30 – 11:45 a.m.
Personalized Medicine in the Clinic: Advances in Diagnosis and Treatment of Cancer
Panelists:
- Franklyn G. Prendergast, MD, PhD, Director, Center for Individualized Medicine Research, Mayo Clinic
- Randy Scott, PhD, Chairman & CEO, Genomic Health
- Jeff Trent, PhD, President & Scientific Director, Translational Genomics Research Institute (TGen)
- William D. Young, Chairman & CEO, Monogram Biosciences
Moderator: Caroline A. Kovac, PhD, Managing Director, Burrill & Company


11:45 a.m. – 1:15 p.m.
‘Conversations with Experts’ Luncheon
Informal discussions on business, economic, political and therapeutic topics with an international group of personalized medicine leaders from corporate, academic and government sectors.
Expert Hosts:
- Mari Baker, President & CEO, Navigenics
- Asif Dhar, MD, Senior Manager, Deloitte Consulting
- Eugenia Garret-Wackowski, Partner, Townsend and Townsend and Crew LLP
- Sami N. Guzder, Chief Scientist, Avesthagen
- Matthew Hudes, National Managing Principal, Deloitte Consulting
- Robert J. Monroe, MD, PhD, CMO, BioImagene
- Franklyn G. Prendergast, MD, PhD, Director, Center for Individualized Medicine Research, Mayo Clinic
- Randy Scott, PhD, Chairman & CEO, Genomic Health
- John J. Sninsky, PhD, VP, Discovery Research, Celera
- Eric J. Topol, MD, Director, Scripps Translational Science Institute; Dean, Scripps School of Medicine; Chief Academic Officer, Scripps Health
- William Wachsman, MD, PhD, Associate Professor, Medicine, UCSD

1:15 – 2:15 p.m.
Interview: The FDA and Regulatory Approval
- Alberto Gutierrez, PhD, Deputy Director, New Product Evaluation, Office of In Vitro Diagnostic Device Evaluation and Safety (OIVD), Center for Devices and Radiological Health (CDRH), FDA
Interviewed by: Ann F. Hanham, PhD, Managing Director, Burrill & Company

2:15 – 2:30 p.m.
Break

2:30 – 3:15 p.m.
Keynote Speaker: Personalized Medicine After Herceptin
- Susan Desmond-Hellmann, MD, MPH, President, Product Development, Genentech
Introduced by: William D. Young, Chairman & CEO, Monogram Biosciences

3:15 – 4:30 p.m.
Personalized Medicine in the Clinic: Beyond Cancer
Panelists:
- Dean Sproles, CEO, Iverson Genetics Diagnostics
- Timothy Thompson, President & CEO, Proventys
- Eric J. Topol, MD, Director, Scripps Translational Science Institute; Dean, Scripps School of Medicine; Chief Academic Officer, Scripps Health
Moderator: Garrett Vygantas, MD, Senior Associate, Burrill & Company

4:30 – 5:00 p.m.
Presentation: Personalized Medicine - The Challenges Ahead

- Paul H. Keckley, PhD, Executive Director, Deloitte Center for Health Solutions

5:00 p.m.
Day One Meeting Wrap-Up
- Caroline A. Kovac, PhD, Managing Director, Burrill & Company

5:00 – 6:30 p.m.
Networking Reception



Tuesday, November 11, 2008

7:30 – 8:30 a.m.
Breakfast

8:30 – 10:00 a.m.
Personalized Medicine and Public Policy
Panelists:
- M. Kathleen Behrens, PhD, Member, President’s Council of Advisors on Science and Technology
- Kathryn Lowell, Deputy Secretary, Health Systems and Life Sciences Business, Transportation and Housing Agency
- Robert Wells, Partner, HealthFutures, LLC
Moderator: Caroline A. Kovac, PhD, Managing Director, Burrill & Company

10:00– 10:30 a.m.
Break

10:30 a.m. – 12:00 p.m.
Patient-Centric Medicine: PM from the Patient’s Point of View
Panelists:
- Mari Baker, President & CEO, Navigenics
- Michael F. Christman, PhD, President & CEO, Coriell Institute for Medical Research
- Steven A. R. Murphy, MD, President, Helix Health & The Gene Sherpa
Moderator: Caroline A. Kovac, PhD, Managing Director, Burrill & Company

12:00 – 1:00 p.m.
Lunch

1:00 – 2:30 p.m.
Changing Business Models in Personalized Medicine
Panelists:
- Matt Hudes, National Managing Principal, Deloitte Consulting
- Michael Paul, PhD, President & CEO, LineaGen
- Bruce Quinn, MD, PhD, Senior Health Policy Specialist, Foley Hoag; Former California Medical Director, NHIC
- William J. Welch, SVP & Chief Commercial Officer, Monogram Biosciences
Moderator: Mohan S. Iyer, Managing Director, Burrill & Company

2:30 – 2:45 p.m.
Meeting Wrap-Up
- Caroline A. Kovac, PhD, Managing Director, Burrill & Company


**all times and speakers are subject to change